Table 1.
Whole blood cell analysis of mice after treatment with LPA or analogues.
| Index | Control | LPA | Analogues |
|---|---|---|---|
| WBC (×10 9 /L) | 6.33 ± 1.57 | 6.33 ± 2.01 | 6.27 ± 1.81 |
| Lymph (×10 9 /L) | 1.85 ± 0.28 | 1.80 ± 0.22 | 1.87 ± 0.24 |
| Mon (×10 9 /L) | 0.35 ± 0.19 | 0.30 ± 0.14 | 0.30 ± 0.14 |
| Gran (×10 9 /L) | 3.26 ± 0.52 | 3.16 ± 1.01 | 2.90 ± 0.16 |
| Lymph (%) | 34.47 ± 8.91 | 38.20 ± 9.38 | 33.70 ± 2.21 |
| Mon (%) | 4.98 ± 0.84 | 4.73 ± 1.06 | 4.97 ± 0.19 |
| Gran (%) | 59.62 ± 7.60 | 56.73 ± 10.10 | 59.33 ± 3.45 |
| RBC (×10 12 /L) | 8.98 ± 0.52 | 9.04 ± 0.53 | 9.09 ± 0.30 |
| HGB (g/L) | 141.00 ± 5.81 | 137.00 ± 2.16 | 143.67 ± 9.53 |
| HCT (%) | 46.13 ± 3.23 | 41.73 ± 8.06 | 46.63 ± 4.69 |
| MCV (fL) | 48.27 ± 3.93 | 48.67 ± 0.45 | 46.50 ± 4.81 |
| MCH (pg) | 15.57 ± 2.25 | 15.77 ± 1.51 | 15.20 ± 0.78 |
| MCHC (g/L) | 316.30 ± 5.80 | 303.30 ± 21.10 | 314.33 ± 2.36 |
| RDW (%) | 15.87 ± 2.81 | 15.57 ± 2.25 | 15.17 ± 0.57 |
| PLT (×10 9 /L) | 809.67 ± 80.5 | 767.33 ± 51.65 | 836.67 ± 226.18 |
| MPV (fL) | 5.52 ± 0.82 | 5.97 ± 0.70 | 5.83 ± 0.21 |
| PDW | 17.53 ± 0.35 | 17.43 ± 0.33 | 17.50 ± 0.22 |
| PCT (%) | 0.38 ± 0.17 | 0.39 ± 0.11 | 0.35 ± 0.15 |
WBC: white blood cell; Lymph: lymphocyte; Mon: monocyte; Gran: granulocyte; RBC: red blood cell; HGB: hemoglobin; HCT: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW: red blood cell distribution width; PLT: platelets; MPV: mean platelet volume; PDW: platelet distribution width; PCT: plateletcrit.